Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals, Inc. (TERN) Tax Provisions (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Tax Provisions for 4 consecutive years, with $72000.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Tax Provisions changed N/A year-over-year to $72000.0, compared with a TTM value of $409000.0 through Jun 2023, changed N/A, and an annual FY2024 reading of $260000.0, up 8.79% over the prior year.
  • Tax Provisions was $72000.0 for Q2 2023 at Terns Pharmaceuticals, up from $60000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $711000.0 in Q4 2020 and bottomed at $13000.0 in Q3 2022.
  • Average Tax Provisions over 4 years is $173000.0, with a median of $66000.0 recorded in 2023.
  • The sharpest move saw Tax Provisions crashed 80.39% in 2021, then crashed 35.0% in 2022.
  • Year by year, Tax Provisions stood at $711000.0 in 2020, then crashed by 38.82% to $435000.0 in 2021, then tumbled by 39.31% to $264000.0 in 2022, then tumbled by 72.73% to $72000.0 in 2023.
  • Business Quant data shows Tax Provisions for TERN at $72000.0 in Q2 2023, $60000.0 in Q1 2023, and $264000.0 in Q4 2022.